In developing countries, there is a need for a simple but effective system to monitor the safety of medications during pregnancy. There are currently no established systems to monitor drug safety in pregnancy in malaria endemic countries. Stéphanie Dellicour develops and evaluates pharmacovigilance systems in resource constrained settings to provide a better estimate of the risk-benefit profile of artemisinin-based combination therapies (ACTs), which are now the recommended treatment for uncomplicated malaria.
S.O.M.C. Dellicour, Assessment of Pharmacovigilance Approaches for Monitoring the Safety of Antimalarial Drugs in Pregnancy.
Prof. F.O. ter Kuile
Prof. M. Boele van Hensbroek
Dr M.R. Desai (Muljibhai Patel Urological Hospital, India)
This event is open to the public.